Glycosylation as a marker for inflammatory arthritis

Cancer Biomarkers

Volumn 14, Issue 1, 2014, Pages 17-28

  Albrecht, Simone ^a   Unwin, Louise ^a   Muniyappa, Mohankumar ^a,b   Rudd, Pauline M ^b  

^a NATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

aetiopathology; diagnostics; Inflammatory arthritis; serum protein glycosylation; therapy

Indexed keywords

FLUORESCENT DYE; GLYCAN; IMMUNOGLOBULIN G; PLASMA PROTEIN; BIOLOGICAL MARKER; GLYCOPROTEIN;

ARTICLE; DISEASE ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; LIFESTYLE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RHEUMATOID ARTHRITIS; ARTHRITIS, RHEUMATOID; BLOOD; GLYCOSYLATION; METABOLISM;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BLOOD PROTEINS; GLYCOPROTEINS; GLYCOSYLATION; HUMANS;

EID: 84901855345     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-130373     Document Type: Article

References (128)

1. F. Nimmerjahn and J.V. Ravetch, Fc-receptors as regulators of immunity, in: Advances in immunology, vol 96, F.W. Alt, K.F. Austen, T. Honjo, F. Melchers, J.W. Uhr and E.R. Unanue (eds.), Elsevier Academic Press Inc, San Diego, 2007, pp. 179-204.
2. O. Vagin, E. Tokhtaeva, I. Yakubov, E. Shevchenko and G. Sachs, Inverse correlation between the extent of N-glycan branching and intercellular adhesion in epithelia - contribution of the Na,K-ATPase beta(1) subunit, J Biol Chem 283 (2008), 2192-2202.
3. P.M. Rudd, M. Butler, I.A. Wilson, J. Jaeken and R.A. Dwek, Roles for glycosylation in the immune system, Glycobiology 11 (2001), 865-865.
4. J.N. Arnold, M.R. Wormald, R.B. Sim, P.M. Rudd and R.A. Dwek, The impact of glycosylation on the biological function and structure of human immunoglobulins, Annu Rev Immunol 25 (2007), 21-50.
5. R.T. Lee, G. Lauc and Y.C. Lee, Glycoproteomics: Protein modifications for versatile functions. Meeting on glycoproteomics, EMBO Rep 6 (2005), 1018-1022.
6. G. Lauc, Sweet secret of the multicellular life, Biochim Biophys Acta 1760 (2006), 525-526.
7. K. Ohtsubo and J.D. Marth, Glycosylation in cellular mechanisms of health and disease, Cell 126 (2006), 855-867.
8. M.M. Chavan, P.D. Kawle and N.G. Mehta, Increased sialylation and defucosylation of plasma proteins are early events in the acute phase response, Glycobiology 15 (2005), 838-848.
9. G.O. Storey, M. Comer and D.L. Scott, Chronic arthritis before 1876: Early british cases suggesting rheumatoid arthritis, Ann Rheum Dis 53 (1994), 557-60.
10. D.L. Scott, F. Wolfe and T.W. Huizinga, Rheumatoid arthritis, Lancet 376 (2010), 1094-108.
11. A.J. Landre-Beauvais, The first description of rheumatoid arthritis. Unabridged text of the doctoral dissertation presented in 1800, Joint Bone Spine 68 (2001), 130-143.
12. V. Majithia and S.A. Geraci, Rheumatoid arthritis: Diagnosis and management, Am J Med 120 (2007), 936-939.
13. J. Ahn, J. Bones, Y.Q. Yu, P.M. Rudd and M. Gilar, Separation of 2-aminobenzamide labeled glycans using hydrophilic interaction chromatography columns packed with 1.7 μm sorbent, J Chromatogr B 878 (2010), 403-408.
14. M. Melmer, T. Stangler, M. Schiefermeier, W. Brunner, H. Toll, A. Rupprechter, W. Lindner and A. Premstaller, HILIC analysis of fluorescence-labeled N-glycans from recombinant biopharmaceuticals, Anal Bioanal Chem 398 (2010), 905-914.
15. L. Royle, M.P. Campbell, C.M. Radcliffe, D.M. White, D.J. Harvey, J.L. Abrahams, Y.-G. Kim, G.W. Henry, N.A. Shadick, M.E. Weinblatt, D.M. Lee, P.M. Rudd and R.A. Dwek, HPLC-based analysis of serum N-glycans on a 96- well plate platform with dedicated database software, Anal Biochem 376 (2008), 1-12.
16. A. Knezevic, O. Polasek, O. Gornik, I. Rudan, H. Campbell, C. Hayward, A. Wright, I. Kolcic, N. O'Donoghue, J. Bones, P.M. Rudd and G. Lauc, Variability, heritability and environmental determinants of human plasma N-glycome, J Proteome Res 8 (2009), 694-701.
17. M. Pucic, A. Knezevic, J. Vidic, B. Adamczyk, M. Novokmet, O. Polasek, O. Gornik, S. Supraha-Goreta, M.R. Wormald, I. Redzic, H. Campbell, A. Wright, N.D. Hastie, J.F. Wilson, I. Rudan, M. Wuhrer, P.M. Rudd, D. Josic and G. Lauc, High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations, Mol Cell Proteomics 10 (2011), DOI: 10.1074/mcp.M111.010090.
18. M. Wuhrer, J.C. Stam, F.E. van de Geijn, C.A.M. Koeleman, C.T. Verrips, R. Dolhain, C.H. Hokke and A.M. Deelder, Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum, Proteomics 7 (2007), 4070-4081.
19. H.J. Jeong, Y.G. Kim, Y.H. Yang and B.G. Kim, Highthroughput quantitative analysis of total N-glycans by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, Anal Chem 84 (2012), 3453-3460.
20. G. Zauner, A.M. Deelder and M. Wuhrer, Recent advances in hydrophilic interaction liquid chromatography (HILIC) for structural glycomics, Electrophoresis 32 (2011), 3456-3466.
21. M.P. Campbell, L. Royle, C.M. Radcliffe, R.A. Dwek and P.M. Rudd, Glyco Base and auto GU: Tools for HPLC-based glycan analysis, Bioinformatics 24 (2008), 1214-1216.
22. C.-W. von der Lieth, A.A. Freire, D. Blank, M.P. Campbell, A. Ceroni, D.R. Damerell, A. Dell, R.A. Dwek, B. Ernst, R. Fogh, M. Frank, H. Geyer, R. Geyer, M.J. Harrison, K. Henrick, S. Herget, W.E. Hull, J. Ionides, H.J. Joshi, J.P. Kamerling, B.R. Leeflang, T. Lutteke, M. Lundborg, K. Maass, A. Merry, R. Ranzinger, J. Rosen, L. Royle, P.M. Rudd, S. Schloissnig, R. Stenutz, W.F. Vranken, G. Widmalm and S.M. Haslam, EURO Carb DB: An open-access platform for glycoinformatics, Glycobiology 21 (2011), 493-502.
23. K. Marino, J. Bones, J.J. Kattla and P.M. Rudd, A systematic approach to protein glycosylation analysis: A path through the maze, Nat Chem Biol 6 (2010), 713-723.
24. C. Huhn, M.H.J. Selman, L.R. Ruhaak, A.M. Deelder and M. Wuhrer, IgG glycosylation analysis, Proteomics 9 (2009), 882-913.
25. L.R. Ruhaak, A.M. Deelder and M. Wuhrer, Oligosaccharide analysis by graphitized carbon liquid chromatography-mass spectrometry, Anal Bioanal Chem 394 (2009), 163-174.
26. M. Pioch, S.C. Bunz and C. Neususs, Capillary electrophoresis/mass spectrometry relevant to pharmaceutical and biotechnological applications, Electrophoresis 33 (2012), 1517-1530.
27. T.T. Yue and B.B. Haab, Microarrays in glycoproteomics research, Clin Lab Med 29 (2009), 15-29.
28. P.M. Rudd, R.J. Leatherbarrow, T.W. Rademacher and R.A. Dwek, Diversification of the IgG molecule by oligosaccharides, Mol Immunol 28 (1991), 1369-1378.
29. J. Barratt, E.M. Bailey, K.S. Buck, J. Mailley, P. Moayyedi, J. Feehally, J.H. Turney, J.E. Crabtree and A.C. Allen, Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathy, Am J Kidney Dis 33 (1999), 1049-1057.
30. J. Alper, Searching for medicine's sweet spot, Science 291 (2001), 2338-2343.
31. H. Stibler, Carbohydrate-deficient transferrin in serum: A new marker of potentially harmful alcohol consumption reviewed, Clin Chem 37 (1991), 2029-2037.
32. S. Thompson, E. Dargan, I.D. Griffiths, C.A. Kelly and G.A. Turner, The glycosylation of haptoglobin in rheumatoid arthritis, Clin Chim Acta 220 (1993), 107-114.
33. G. de Jong, J.P. van Dijk and H.G. van Eijk, The biology of transferrin, Clin Chim Acta 190 (1990), 1-46.
34. K. Yamashita, N. Koide, T. Endo, Y. Iwaki and A. Kobata, Altered glycosylation of serum transferrin of patients with hepatocellular carcinoma, J Biol Chem 264 (1989), 2415-23.
35. L. Sturiale, R. Barone, A. Fiumara, M. Perez, M. Zaffanello, G. Sorge, L. Pavone, S. Tortorelli, J.F. O'Brien, J. Jaeken and D. Garozzo, Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia, Glycobiology 15 (2005), 1268-1276.
36. C. Panzironi, B. Silvestrini, M.Y. Mo, R. Lahita, D. Mruk and C.Y. Cheng, An increase in the carbohydrate moiety of alpha(2)-macroglobulin is associated with systemic lupus erythematosus (SLE), Biochem Mol Biol Int 43 (1997), 1305-1322.
37. T. Das, A.K. Sen, T. Kempf, S.R. Pramanik and C. Mandal, Induction of glycosylation in human C-reactive protein under different pathological conditions, Biochem J 373 (2003), 345-355.
38. T. Das and C. Mandal, Variations in binding characteristics of glycosylated human C-reactive proteins in different pathological conditions, Glycoconj J 20 (2004), 537-543.
39. K.S. Nandakumar, M. Collin, A. Olsen, F. Nimmerjahn, A.M. Blom, J.V. Ravetch and R. Holmdahl, Endoglycosidase treatment abrogates IgG arthritogenicity: Importance of IgG glycosylation in arthritis, Eur J Immunol 37 (2007), 2973-2982.
40. M. Holland, K. Takada, T. Okumoto, N. Takahashi, K. Kato, D. Adu, A. Ben-Smith, L. Harper, C.O.S. Savage and R. Jefferis, Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis, Clin Exp Immunol 129 (2002), 183-190.
41. I. Perdivara, S.D. Peddada, F.W. Miller, K.B. Tomer and L.J. Deterding, Mass spectrometric determination of IgG subclass-specific glycosylation profiles in siblings discordant for myositis syndromes, J Proteome Res 10 (2011), 2969-2978.
42. M. Tomana, R.E. Schrohenloher, W.J. Koopman, G.S. Alarcon and W.A. Paul, Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases, Arthritis Rheum 31 (1988), 333-338.
43. Y. Kanoh, T. Mashiko, M. Danbara, Y. Takayama, S. Ohtani, T. Imasaki, T. Abe and T. Akahoshi, Analysis of the oligosaccharide chain of human serum immunoglobulin G in patients with localized or metastatic cancer, Oncology 66 (2004), 365-370.
44. K. Kodar, J. Stadlmann, K. Klaamas, B. Sergeyev and O. Kurtenkov, Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: Relation to tumor progression and survival, Glycoconj J 29 (2012), 57-66.
45. R. Saldova, L. Royle, C.M. Radcliffe, U.M.A. Hamid, R. Evans, J.N. Arnold, R.E. Banks, R. Hutson, D.J. Harvey, R. Antrobus, S.M. Petrescu, R.A. Dwek and P.M. Rudd, Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG, Glycobiology 17 (2007), 1344-1356.
46. C. Gabay and I. Kushner, Acute-phase proteins and other systemic responses to inflammation, N Engl J Med 340 (1999), 448-454.
47. M.A. Elliott, H.G. Jørgensen and K.D. Smith, Hypersialylation of α1-acid glycoprotein in rheumatoid arthritis, Pharm Pharmacol Commun 4 (1998), 545-547.
48. S. Thompson, C.A. Kelly, I.D. Griffiths and G.A. Turner, Abnormally-fucosylated serum haptoglobins in patients with inflammatory joint disease, Clin Chim Acta 184 (1989), 251-258.
49. E. Dempsey and P.M. Rudd, Acute phase glycoproteins: Bystanders or participants in carcinogenesis? Ann NY Acad Sci 1253 (2012), 122-132.
50. H. Albert, M. Collin, D. Dudziak, J.V. Ravetch and F. Nim merjahn, In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner, Nat Acad Sci Proc 105 (2008), 15005-15009.
51. R.B. Parekh, R.A. Dwek, B.J. Sutton, D.L. Fernandes, A. Leung, D. Stanworth, T.W. Rademacher, T. Mizuochi, T. Taniguchi, K. Matsuta, F. Takeuchi, Y. Nagano, T. Miyamoto and A. Kobata, Association of rheumatoid-arthritis and primary osteo-arthritis with changes in the glycosylation pattern of total serum IgG, Nature 316 (1985), 452-457.
52. R.B. Parekh, D.A. Isenberg, B.M. Ansell, I.M. Roitt, R.A. Dwek and T.W. Rademacher, Galactosylation of IgG associated oligosaccharides - reduction in patients with adult and juvenile onset rheumatoid-arthritis and relation to diseaseactivity, Lancet 1 (1988), 966-969.
53. A. Alavi and J.S. Axford, Glyco-biomarkers: Potential determinants of cellular physiology and pathology, Dis Markers 25 (2008), 193-205.
54. A. Alavi and J.S. Axford, Sweet and sour: The impact of sugars on disease, Rheumatology 47 (2008), 760-770.
55. O. Gornik and G. Lauc, Glycosylation of serum proteins in inflammatory diseases, Dis Markers 25 (2008), 267-278.
56. H. Das, T. Atsumi, Y. Fukushima, H. Shibuya, K. Ito, Y. Yamada, Y. Amasaki, K. Ichikawa, O. Amengual and T. Koike, Diagnostic value of antiagalactosyl IgG antibodies in rheumatoid arthritis, Clin Rheumatol 23 (2004), 1218-222.
57. Y. Imafuku, H. Yoshida and Y. Yamada, Reactivity of agalactosyl IgG with rheumatoid factor, Clin Chim Acta 334 (2003), 217-223.
58. A. Matsumoto, K. Shikata, F. Takeuchi, N. Kojima and T. Mizuochi, Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation, J Biochem 128 (2000), 621-628.
59. K.A. Leader, G.C. Lastra, J.R. Kirwan and C.J. Elson, Agalactosyl IgG in aggregates from the rheumatoid joint, Brit J Rheumatol 35 (1996), 335-341.
60. A.J. Soltys, A. Bond, O.M. Westwood and F.C. Hay, The effects of altered glycosylation of IgG on rheumatoid factorbinding and immune complex formation, Adv Exp Med Biol 376 (1995), 155-160.
61. P. Garred, H.O. Madsen, H. Marquart, T.M. Hansen, S.F. Sorensen, J. Petersen, B. Volck, A. Svejgaard, N.A. Graudal, P.M. Rudd, R.A. Dwek, R.B. Sim and V. Andersen, Two edged role of mannose binding lectin in rheumatoid arthritis: A cross sectional study, J Rheumatol 27 (2000), 26-34.
62. R. Malhotra, M.R. Wormald, P.M. Rudd, P.B. Fischer, R.A. Dwek and R.B. Sim, Glycosylation changes of IgG associated with rheumatoid-arthritis can activate complement via the mannose-binding protein, Nat Med 1 (1995), 237-243.
63. Y. Kaneko, F. Nimmerjahn and E.V. Ravetch, Antiinflammatory activity of immunoglobulin G resulting from Fc sialylation, Science 313 (2006), 670-673.
64. M. Watson, P.M. Rudd, M. Bland, R.A. Dwek and J.S. Axford, Sugar printing rheumatic diseases: A potential method for disease differentiation using immunoglobulin G oligosaccharides, Arthritis Rheum 42 (1999), 1682-1690.
65. R. Niwa, A. Natsume, A. Uehara, M. Wakitani, S. Iida, K. Uchida, M. Satoh and K. Shitara, IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn(297)-linked oligosaccharides, J Immunol Meth 306 (2005), 151-160.
66. T. Shinkawa, K. Nakamura, N. Yamane, E. Shoji-Hosaka, Y. Kanda, M. Sakurada, K. Uchida, H. Anazawa, M. Satoh, M. Yamasaki, N. Hanai and K. Shitara, The absence of fucose but not the presence of galactose or bisecting Nacetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibodydependent cellular cytotoxicity, J Biol Chem 278 (2003), 3466-3473.
67. J.F. Fries, C.A. Williams, D. Morfeld, G. Singh and J. Sibley, Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies, Arthritis Rheum 39 (1996), 616-622.
68. D. Aletaha, T. Neogi, A.J. Silman, J. Funovits, D.T. Felson, C.O. Bingham, N.S. Birnbaum, G.R. Burmester, V.P. Bykerk, M.D. Cohen, B. Combe, K.H. Costenbader, M. Dougados, P. Emery, G. Ferraccioli, J.M.W. Hazes, K. Hobbs, T.W.J. Huizinga, A. Kavanaugh, J. Kay, T.K. Kvien, T. Laing, P. Mease, H.A. Menard, L.W. Moreland, R.L. Naden, T. Pincus, J.S. Smolen, E. Stanislawska-Biernat, D. Symmons, P.P. Tak, K.S. Upchurch, J. Vencovsky, F. Wolfe and G. Hawker, Rheumatoid arthritis classification criteria: An american college of rheumatology/european league against rheumatism collaborative initiative, Arthritis Rheum 62 (2010), 2569-2581.
69. S. Rantapaa-Dahlqvist, B.A.W. de Jong, E. Berglin, G. Hallmans, G. Wadell, H. Stenlund, U. Sundin and W.J. van Venrooij, Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis, Arthritis Rheum 48 (2003), 2741-2749.
70. U. Sauerland, H. Becker, M. Seidel, H. Schotte, P. Willeke, A. Schorat, B. Schluter, W. Domschke and M. Gaubitz, Clinical utility of the anti-CCP assay - experiences with 700 patients, in: Autoimmunity: Concepts and diagnosis at the cutting edge, M.E. Gershwin and Y. Shoeenfeld (eds.), New York Acad Sciences, New York, 2005, pp. 314-318.
71. I. Vallbracht, J. Rieber, M. Oppermann, F. Forger, U. Siebert and K. Helmke, Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis, Ann Rheum Dis 63 (2004), 1079-1084.
72. A. Ercan, J. Cui, D.E.W. Chatterton, K.D. Deane, M.M. Hazen, W. Brintnell, C.I. O'Donnell, L.A. Derber, M.E. Weinblatt, N.A. Shadick, D.A. Bell, E. Cairns, D.H. Solomon, V.M. Holers, P.M. Rudd and D.M. Lee, Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis, Arthritis Rheum 62 (2010), 2239-2248.
73. R.B. Parekh, R.A. Dwek, B.J. Sutton, D.L. Fernandes, A. Leung, D. Stanworth, T.W. Rademacher, T. Mizuochi, T. Taniguchi, K. Matsuta and et al., Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG, Nature 316 (1985), 452-7.
74. A. Young, N. Sumar, K. Bodman, S. Goyal, H. Sinclair, I. Roitt and D. Isenberg, Agalactosyl IgG - an aid to differential-diagnosis in early synovitis, Arthritis Rheum 34 (1991), 1425-1429.
75. K. Forslind, M. Ahlmen, K. Eberhardt, I. Hafstrom, B. Svensson and B.S. Grp, Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: Role of antibodies to citrullinated peptides (anti-CCP), Ann Rheum Dis 63 (2004), 1090-1095.
76. C. Turesson, L.T.H. Jacobsson, G. Sturfelt, E.L. Matteson, L. Mathsson and J. Ronnelid, Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis, Ann Rheum Dis 66 (2007), 59-64.
77. F. Humby, M. Bombardieri, A. Manzo, S. Kelly, M.C. Blades, B. Kirkham, J. Spencer and C. Pitzalis, Ectopic lymphoid structures support ongoing production of classswitched autoantibodies in rheumatoid synovium, Plos Medicine 6 (2009), 59-75.
78. H.U. Scherer, D. van der Woude, A. Ioan-Facsinay, H. el Bannoudi, L.A. Trouw, J. Wang, T. Haupl, G.R. Burmester, A.M. Deelder, T.W.J. Huizinga, M. Wuhrer and R.E.M. Toes, Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid, Arthritis Rheum 62 (2010), 1620-1629.
79. A. Ercan, J. Cui, M. Hazen, F. Batliwalla, L. Royle, P. Rudd, J. Coblyn, N. Shadick, M. Weinblatt, P. Gregersen, D. Lee and P. Nigrovic, Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis, Arthritis Res Ther 14 (2012), R43.
80. R.M. Anthony, F. Nimmerjahn, D.J. Ashline, V.N. Reinhold, J.C. Paulson and J.V. Ravetch, Recapitulation of IVIG antiinflammatory activity with a recombinant IgG FC, Science 320 (2008), 373-376.
81. A. Ioan-Facsinay, A. Willemze, D.B. Robinson, C.A. Peschken, J. Markland, D. van der Woude, B. Elias, H.A. Menard, M. Newkirk, M.J. Fritzler, R.E.M. Toes, T.W.J. Huizinga and H.S. El-Gabalawy, Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease, Arthritis Rheum 58 (2008), 3000-3008.
82. K. Martin, R. Talukder, F.C. Hay and J.S. Axford, Characterization of changes in IgG associated oligosaccharide profiles in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis using fluorophore linked carbohydrate electrophoresis, J Rheumatol 28 (2001), 1531-1536.
83. J.S. Axford, G. Cunnane, O. Fitzgerald, J.M. Bland, B. Bresnihan and E.R. Frears, Rheumatic disease differentiation using immunoglobulin G sugar printing by high density electrophoresis, J Rheumatol 30 (2003), 2540-2546.
84. E. Gindzienska-Sieskiewicz, P.A. Klimiuk, D.G. Kisiel, A. Gindzienski and S. Sierakowski, The changes in monosaccharide composition of immunoglobulin G in the course of rheumatoid arthritis, Clin Rheumatol 26 (2007), 685-690.
85. J.K. Lacki, W. Porawska, U. Mackiewicz, S. Mackiewicz and W. Muller, Changes in agalactosyl IgG levels correlate with radiological progression in early rheumatoid arthritis, Ann Med 28 (1996), 265-269.
86. R. Parekh, D. Isenberg, B. Ansell, I. Roitt, R. Dwek and T. Rademacher, Galactosylation of IgG associated oligosaccharides: Reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity, The Lancet 331 (1988), 966-969.
87. N. Tsuchiya, T. Endo, M. Shiota, N. Kochibe, K. Ito and A. Kobata, Distribution of glycosylation abnormality among serum IgG subclasses from patients with rheumatoidarthritis, Clin Immunol Immunopathol 70 (1994), 47-50.
88. M. Flogel, G. Lauc, I. Gornik and B. Macek, Fucosylation and galactosylation of IgG heavy chains differ between acute and remission phases of juvenile chronic arthritis, Clin Chem Lab Med 36 (1998), 99-102.
89. A. Alavi, N. Arden, T.D. Spector and J.S. Axford, IgG glycosylation changes are associated with the clinical outcome of rheumatoid arthritis in pregnancy, Arthritis Rheum 40 (1997), 711.
90. E.C. Havenaar, J.S. Axford, E.C.M. Brinkman-van der Linden, A. Alavi, E.C.R. Van Ommen, B. van het Hof, T. Spector, A. Mackiewicz and W. Van Dijk, Severe rheumatoid arthritis prohibits the pregnancy-induced decrease in alpha 3-fucosylation of alpha(1)-acid glycoprotein, Glycoconj J 15 (1998), 723-729.
91. J.M. Pekelharing, E. Hepp, J.P. Kamerling, G.J. Gerwig and B. Leijnse, Alterations in carbohydrate-composition of serum IgG from patients with rheumatoid-arthritis and from pregnant women, Ann Rheum Dis 47 (1988), 91-95.
92. F.E. van de Geijn, M. Wuhrer, M.H.J. Selman, S.P. Willemsen, Y.A. de Man, A.M. Deelder, J.M.W. Hazes and R. Dolhain, Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: Results from a large prospective cohort study, Arthritis Res Ther 11 (2009), DOI: 10.1186/ar2892
93. E.C.M. Brinkman Vander Linden, E.C. Havenaar, E.C.R. Van Ommen, G.J. Van Kamp, L.J.G. Gooren and W. Van Dijk, Oral estrogen treatment induces a decrease in expression of sialyl Lewis x on alpha(1)-acid glycoprotein in females and male-to-female transsexuals, Glycobiology 6 (1996), 407-412.
94. W. Van Dijk and A. Mackiewicz, Interleukin-6-type cytokine-induced changes in acute phase protein glycosylation, in: Interleukin-6 type cytokines, A. Mackiewicz, A. Koj and P.B. Sehgal (eds.), New York Acad Sciences, New York, 1995, pp. 319-330.
95. Y.A. de Man, L.E. Bakker-Jonges, C.M. Dufour-van den Goorbergh, S.P.R. Tillemans, H. Hooijkaas, J.M.W. Hazes and R. Dolhain, Women with rheumatoid arthritis negative for anti-cyclic citrullinated peptide and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody-positive women autoantibody levels are not influenced by pregnancy, Ann Rheum Dis 69 (2010), 420-423.
96. M. Feldmann, F.M. Brennan and R.N. Maini, Role of cytokines in rheumatoid arthritis, Annu Rev Immunol 14 (1996), 397-440.
97. B.N. Cronstein, M.A. Eberle, H.E. Gruber and R.I. Levin, Methotrexate inhibits neutrophil function by stimulating adenosine release from connective-tissue cells, Proc Natl Acad Sci USA 88 (1991), 2441-2445.
98. E.S. Collins, M.C. Galligan, R. Saldova, B. Adamczyk, J.L. Abrahmans, M.P. Campbell, C.-T. Ng, D.J. Veale, T.B. Murphy, P.M. Rudd and O. Fitz Gerald, Glycosylation status of serum in inflammatory arthritis in response to anti-TNF treatment, Rheumatology 52 (2013), 1572-1582.
99. A. Croce, O. Firuzi, F. Altieri, M. Eufemi, R. Agostino, R. Priori, M. Bombardieri, C. Alessandri, G. Valesini and L. Saso, Effect of infliximab on the glycosylation of IgG of patients with rheumatoid arthritis, J Clin Lab Anal 21 (2007), 303-314.
100. M. Pasek, M. Duk, M. Podbielska, R. Sokolik, J. Szechinski, E. Lisowska and H. Krotkiewski, Galactosylation of IgG from rheumatoid arthritis (RA) patients - changes during therapy, Glycoconj J 23 (2006), 463-471.
101. K. Van Beneden, K. Coppieters, W. Laroy, F. De Keyser, I.E. Hoffman, F. Van den Bosch, B.V. Cruyssen, M. Drennan, P. Jacques, P. Rottiers, G. Verbruggen, R. Contreras, N. Callewaert and D. Elewaut, Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis, Ann Rheum Dis 68 (2009), 1360-1365.
102. A. Crore, O. Firuzi, F. Altieri, M. Eufemi, R. Agostino, R. Priori, M. Bombardieri, C. Alessandri, G. Valesini and L. Saso, Effect of infliximab on the glycosylation of IgG of patients with rheumatoid arthritis, J Clin Lab Anal 21 (2007), 303-314.
103. T.W. de Graaf, E.C.R. van Ommen, M.E. van der Stelt, P. Kerstens, A.M.T. Boerbooms and W. van Dijk, Effects of low-dose methotrexate therapy on the concentration and the glycosylation of alpha(1)-acid glycoprotein in the serum of patients with rheumatoid-arthritis - a longitudinal-study, J Rheumatol 21 (1994), 2209-2216.
104. A. Olewicz-Gawlik, I. Korczowska-Lacka, J.K. Lacki, K. Klama and P. Hrycaj, Fucosylation of serum alpha(1)-acid glycoprotein in rheumatoid arthritis patients treated with infliximab, Clin Rheumatol 26 (2007), 1679-1684.
105. R. Saldova, J.E. Huffman, B. Adamczyk, A. Muzinic, J.J. Kattla, M. Pucic, M. Novokmet, J.L. Abrahams, C. Hayward, I. Rudan, S.H. Wild, A.F. Wright, O. Polasek, G. Lauc, H. Campbell, J.F. Wilson and P.M. Rudd, Association of medication with the human plasma N-glycome, J Proteome Res 11 (2012), 1821-1831.
106. K.L. Hyrich, K.D. Watson, A.J. Silman, D.P.M. Symmons and T.B.B. Register, Predictors of response to anti-TNF-α therapy among patients with rheumatoid arthritis: Results from the british society for rheumatology biologics register, Rheumatology 45 (2006), 1558-1565.
107. C.Y. Liu, F. Batliwalla, W.T. Li, A. Lee, R. Roubenoff, E. Beckman, H. Khalili, A. Damle, M. Kern, R. Furie, J. Dupuis, R.M. Plenge, M.J.H. Coenen, T.W. Behrens, J.P. Carulli and P.K. Gregersen, Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis, Mol Med 14 (2008), 575-581.
108. J.S. Axford, N. Sumar, A. Alavi, D.A. Isenberg, A. Young, K.B. Bodman and I.M. Roitt, Changes in normal glycosylation mechanisms in autoimmune rheumatic disease, J Clin Invest 89 (1992), 1021-1031.
109. A. Kobata, Function and pathology of the sugar chains of human immunoglobulin G, Glycobiology 1 (1990), 5-8.
110. A. Knezevic, O. Gornik, O. Polasek, M. Pucic, I. Redzic, M. Novokmet, P.M. Rudd, A.F. Wright, H. Campbell, I. Rudan and G. Lauc, Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans, Glycobiology 20 (2010), 959-969.
111. R. Parekh, I. Roitt, D. Isenberg, R. Dwek and T. Rademacher, Age-related galactosylation of the N-linked oligosaccharides of human-serum IgG, J Exp Med 167 (1988), 1731-1736.
112. C.G. Helmick, D.T. Felson, R.C. Lawrence, S. Gabriel, R. Hirsch, C.K. Kwoh, M.H. Liang, H.M. Kremers, M.D. Mayes, P.A. Merkel, S.R. Pillemer, J.D. Reveille, J.H. Stone and W. Natl Arthritis Data, Estimates of the prevalence of arthritis and other rheumatic conditions in the united states, Arthritis Rheum 58 (2008), 15-25.
113. A. Ercan, M.G. Barnes, M. Hazen, H. Tory, L. Henderson, F. Dedeoglu, R.C. Fuhlbrigge, A. Grom, I.A. Holm, M. Kellogg, S. Kim, B. Adamczyk, P.M. Rudd, M. Beth Son, R.P. Sundel, D. Foell, D.N. Glass, S.D. Thompson and P.A. Nigrovic, Multiple juvenile idiopathic arthritis subtypes demonstrate pro-inflammatory IgG glycosylation, Arthritis Rheum (2012), DOI: 10.1002/art.34507.
114. K.J. Murray, M.B. Moroldo, P. Donnelly, S. Prahalad, M.H. Passo, E.H. Giannini and D.N. Glass, Age-specific effects of juvenile rheumatoid arthritis-associated HLA alleles, Arthritis Rheum 42 (1999), 1843-1853.
115. E. Myasoedova, C.S. Crowson, H.M. Kremers, T.M. Therneau and S.E. Gabriel, Is the incidence of rheumatoid arthritis rising? Results from olmsted county, minnesota, 1955-2007, Arthritis Rheum 62 (2010), 1576-1582.
116. J. Wang, C.I.A. Balog, K. Stavenhagen, C.A.M. Koeleman, H.U. Scherer, M.H.J. Selman, A.M. Deelder, T.W.J. Huizinga, R.E.M. Toes and M. Wuhrer, Fc-glycosylation of IgG1 is modulated by B-cell stimuli, Mol Cell Proteomics 10 (2011), DOI: 10.1074/mcp.M110.004655.
117. T.W. de Graaf, M.E. van der Stelt, M.G. Anbergen and W. van Dijk, Inflammation-induced expression of sialyl Lewis x-containing glycan structures on alpha-1-acid glycoprotein (orosomucoid) in human sera, J Exp Med 177 (1993), 657-666.
118. K. Higai, Y. Aoki, Y. Azuma and K. Matsumoto, Glycosylation of site-specific glycans of alpha(1)-acid glycoprotein and alterations in acute and chronic inflammation, Biochim Biophys Acta 1725 (2005), 128-135.
119. E.C.M. Brinkman-van der Linden, P.F. de Haan, E.C. Havenaar and W. van Dijk, Inflammation-induced expression of sialyl Lewis(x) is not restricted to alpha(1)-acid glycoprotein but also occurs to a lesser extent on alpha(1)- antichymotrypsin and haptoglobin, Glycoconj J 15 (1998), 177-182.
120. I. Ryden, P. Pahlsson, A. Lundblad and T. Skogh, Fucosylation of alpha 1-acid glycoprotein (orosomucoid) compared with traditional biochemical markers of inflammation in recent onset rheumatoid arthritis, Clin Chim Acta 317 (2002), 221-229.
121. A. Saroha, S. Biswas, B.P. Chatterjee and H.R. Das, Altered glycosylation and expression of plasma alpha-1-acid glycoprotein and haptoglobin in rheumatoid arthritis, Journal Chromatogr B 879 (2011), 1839-1843.
122. A. Sarrats, R. Saldova, E. Pla, E. Fort, D.J. Harvey, W.B. Struwe, R. de Llorens, P.M. Rudd and R. Peracaula, Glycosylation of liver acute-phase proteins in pancreatic cancer and chronic pancreatitis, Proteom Clin Appl 4 (2010), 432-448.
123. L. Saso, B. Silvestrini, A. Guglielmotti, R. Lahita and C.Y. Cheng, Abnormal glycosylation of alpha(2)-macroglobulin, a non-acute-phase protein, in patients with autoimmunediseases, Inflammation 17 (1993), 465-479.
124. M.T. Goodarzi, J.S. Axford, S.S. Varanasi, A. Alavi, G. Cunnane, O. Fitzgerald and G.A. Turner, Sialyl Lewis(x) expression on IgG in rheumatoid arthritis and other arthritic conditions: A preliminary study, Glycoconj J 15 (1998), 1149-1154.
125. R.A. Feelders, G. Vreugdenhil, G. Dejong, A.J.G. Swaak and H.G. Vaneijk, Transferrin microheterogeneity in rheumatoid-arthritis - relation with disease-activity and anemia of chronic disease, Rheumatol Int 12 (1992), 195-199.
126. M. Grzymislawski, K. Derc, M. Sobieska and K. Wiktorowicz, Microheterogeneity of acute phase proteins in patients with ulcerative colitis, World J Gastroentero 12 (2006), 5191-5195.
127. O. Gornik, I. Gornik, I.Z. Kolednjak and G. Lauc, Change of transferrin sialylation differs between mild sepsis and severe sepsis and septic shock, Internal Med 50 (2011), 861-869.
128. D.J. Harvey, A.H. Merry, L. Royle, M. P. Campbell, R.A. Dwek and P.M. Rudd, Proposal for a standard system for drawing structural diagrams of N- and O-linked carbohydrates and related compounds, Proteomics 9 (2009), 3796-3801.